SNIPETIDE
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

SNIPETIDE Trademark

Serial Number: 98610157 • Registration: 7840323

SNIPETIDE is a trademark filed by CHUGAI SEIYAKU KABUSHIKI KAISHA (CHUGAI PHARMACEUTICAL CO., LTD.) on June 20, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

CHUGAI SEIYAKU KABUSHIKI KAISHA (CHUGAI PHARMACEUTICAL CO., LTD.) (45 trademarks)

NO. 5-1
TOKYO , JP

Entity Type: 03

Trademark Details

Filing Date

June 20, 2024

Registration Date

June 24, 2025

Published for Opposition

May 6, 2025

Goods & Services

Contract biomanufacturing service in the field of pharmaceuticals for others; Contract biomanufacturing service in the field of pharmaceutical compound synthesis for others; Contract biomanufacturing service in the field of peptide synthesis for others

Pharmaceutical preparations for the treatment of infectious or parasitic diseases, neoplasms, diseases of the blood or blood-forming organs, diseases of the immune system, endocrine nutritional or metabolic diseases, mental behavioral or neurodevelopmental disorders, sleep-wake disorders, diseases of the nervous system, diseases of the visual system, diseases of the ear or mastoid process, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin, diseases of the musculoskeletal system or connective tissue, diseases of the genitourinary system, conditions related to sexual health, pregnancy, childbirth or the puerperium, certain conditions originating in the perinatal period, and developmental anomalies; synthetic peptides for medical use for the treatment of infectious or parasitic diseases, neoplasms, diseases of the blood or blood-forming organs, diseases of the immune system, endocrine nutritional or metabolic diseases, mental behavioral or neurodevelopmental disorders, sleep-wake disorders, diseases of the nervous system, diseases of the visual system, diseases of the ear or mastoid process, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin, diseases of the musculoskeletal system or connective tissue, diseases of the genitourinary system, conditions related to sexual health, pregnancy, childbirth or the puerperium, certain conditions originating in the perinatal period, and developmental anomalies; chemical preparations for sanitary use for medical use

Testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; Conducting clinical trials for others; Research and development in the field of biotechnology; Pharmaceutical research into new drugs and development of drugs for others; Pharmaceutical and biological product development consultation relating to peptide; Pharmaceutical and biological product development for others relating to peptide

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 24, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 24, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 6, 2025 NPUB
PUBLISHED FOR OPPOSITION
May 6, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 30, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 8, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 3, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 3, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 3, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 23, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jan 23, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jan 23, 2025 CNRT
ASSIGNED TO EXAMINER
Jan 14, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 13, 2025 NWOS
NEW APPLICATION ENTERED
Jun 20, 2024 NWAP